Article
Author(s):
San Francisco - The known teratogenicity of isotretinoin, as well as a possible link to psychiatric illness, means that physicians prescribing the drug must carefully follow risk-management guidelines. These guidelines are mandated by the FDA.
Elevate-Derm West Conference 2024 Recap
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Reviewing Multiple Subtypes of CHE and Delgocitinib as a Pan-JAK Inhibitor
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Exploring the Atopic Dermatitis Treatment Paradigm and Challenging Cases
Pediatric Melanoma in Review: Providing Considerations for Dermatologists